Literature DB >> 21505978

PDGF-induced proliferation of smooth muscular cells is related to the regulation of CREB phosphorylation and Nur77 expression.

Liyue Wang1, Xiaoyan Dong1, Wei Zhou2, Qiutang Zeng2, Yi Mao3.   

Abstract

This study examined the relationship between PDGF-induced proliferation of vascular smooth muscle cells (VSMCs) and Nur77 expression and the effect of atorvastatin on VSMC proliferation and Nur77 in PDGF-treated VSMCs. Rat VSMCs were isolated and cultured. After incubation with atorvastatin or Nur77 siRNA, the cells were stimulated with PDGF and detected for BrdU incorporation to measure the proliferation of the VSMCs. Quantitative PCR and Western blotting were used to determine the Nur77 protein and the CREB phosphorylation level, to observe their relations with PDGF-induced VSMC proliferation. Our results showed that PDGF increased the BrdU incorporation in VSMCs, suggesting that it induced the proliferation of the cells. The VSMC proliferation was associated with increased Nur77 expression and elevated CREB phosphorylation. Atorvastatin inhibited the PDGF-induced VSMC proliferation, suppressed Nur77 expression. After silencing of Nur77 gene, the PDGF-induced VSMC proliferation was decreased. It was concluded that PDGF-induced VSMC proliferation was related to the Nur77 expression and CREB phosphorylation. Atorvastatin reduced the Nur77 expression and, at the same time, inhibited the VSMC proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505978     DOI: 10.1007/s11596-011-0245-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  28 in total

Review 1.  Inflammation and restenosis in the stent era.

Authors:  Frederick G P Welt; Campbell Rogers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

2.  Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli.

Authors:  Liming Pei; Antonio Castrillo; Mingyi Chen; Alexander Hoffmann; Peter Tontonoz
Journal:  J Biol Chem       Date:  2005-06-17       Impact factor: 5.157

3.  TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells.

Authors:  Vivian de Waard; E Karin Arkenbout; Mariska Vos; Astrid I M Mocking; Hans W M Niessen; Wim Stooker; Bas A J M de Mol; Paul H A Quax; Erik N T P Bakker; Ed VanBavel; Hans Pannekoek; Carlie J M de Vries
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

4.  Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes.

Authors:  C J de Vries; T A van Achterberg; A J Horrevoets; J W ten Cate; H Pannekoek
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

Review 5.  Frontiers in interventional cardiology.

Authors:  E J Topol; P W Serruys
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

6.  Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.

Authors:  R E Law; W P Meehan; X P Xi; K Graf; D A Wuthrich; W Coats; D Faxon; W A Hsueh
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 7.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

8.  Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

Authors:  T Claudel; M D Leibowitz; C Fiévet; A Tailleux; B Wagner; J J Repa; G Torpier; J M Lobaccaro; J R Paterniti; D J Mangelsdorf; R A Heyman; J Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

9.  Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB.

Authors:  Hanna Harant; Ivan J D Lindley
Journal:  Nucleic Acids Res       Date:  2004-10-05       Impact factor: 16.971

10.  The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway.

Authors:  Keith D Baker; Lisa M Shewchuk; Tatiana Kozlova; Makoto Makishima; Annie Hassell; Bruce Wisely; Justin A Caravella; Millard H Lambert; Jeffrey L Reinking; Henry Krause; Carl S Thummel; Timothy M Willson; David J Mangelsdorf
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  3 in total

1.  Induction of Nur77 by hyperoside inhibits vascular smooth muscle cell proliferation and neointimal formation.

Authors:  Yan Huo; Bing Yi; Ming Chen; Nadan Wang; Pengguo Chen; Cheng Guo; Jianxin Sun
Journal:  Biochem Pharmacol       Date:  2014-10-12       Impact factor: 5.858

2.  NR4A1 Knockdown Suppresses Seizure Activity by Regulating Surface Expression of NR2B.

Authors:  Yanke Zhang; Guojun Chen; Baobing Gao; Yunlin Li; Shuli Liang; Xiaofei Wang; Xuefeng Wang; Binglin Zhu
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 3.  The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases.

Authors:  Lei Zhang; Qun Wang; Wen Liu; Fangyan Liu; Ailing Ji; Yanzhang Li
Journal:  J Diabetes Res       Date:  2018-06-14       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.